AXXAM

Event

Swiss Biotech Day 2026 | Axxam

Aurelie

Aurelie Dos Santos,

Business Development Associate BD & Sales Benelux

Meet Axxam at Swiss Biotech Day 2026

Swiss Biotech Day 2026 brings together the global life sciences community for two days of networking, partnering, innovation, and business development in Basel, Switzerland. Organized by the Swiss Biotech Association, the conference has become one of Europe’s leading biotech events, attracting thousands of participants from biotech, pharma, investment, and research organizations worldwide.

The event features:

  • One-to-one partnering meetings
  • International delegations and Global Village activities
  • Company presentations and biotech pitches
  • Sessions focused on AI, R&D, manufacturing, financing, and innovation
  • Networking opportunities across the biotech ecosystem

Aurelie Dos Santos, our Business Development Associate, will attend the conference to connect with biotech and pharmaceutical companies looking for scientific support in early drug discovery and assay development.

Why Swiss Biotech Day Matters

Swiss Biotech Day has grown into a major international meeting point for companies, investors, researchers, and innovation leaders across the life sciences sector. In 2025, the conference attracted more than 3,000 participants from nearly 50 countries, highlighting its role as a global platform for collaboration and partnering.

Advancing Early Drug Discovery Through Integrated Scientific Platforms

Axxam supports partners across multiple therapeutic areas with integrated discovery solutions designed to accelerate early-stage research and generate high-quality experimental data.

Our expertise includes:

  • Biochemical and cell-based assays
  • High-throughput screening
  • High-content imaging
  • iPSC-derived disease models
  • Electrophysiology and organellar electrophysiology
  • Phenotypic screening workflows
  • AI-enabled target discovery support

Let’s connect during the event

If you are attending Swiss Biotech Day 2026 and would like to discuss your discovery program, assay strategy, or potential collaboration opportunities, we would be pleased to connect during the event.

About Axxam

Axxam is a Contract Research Organization (CRO) supporting early drug discovery through integrated assay development, screening, compound management, and advanced in vitro platforms.

Scroll to Top